Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)

• Status: Completed
• Trial end date: 2011-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the effectiveness of 2 IBS treatment strategies:

• Strategy A = MeteoSpasmyl®, on-demand therapy

• Strategy B = standard of care chosen by the physician

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Laboratoires Mayoly Spindler
• Treatments: Alverine; Mebeverine; Parasympatholytics

Criteria

Inclusion Criteria:

• male or female ambulatory patients, aged >= 18 years

• with IBS as defined by Rome III criteria for more than 1 year and less than 10 years

• with a IBS-SSS between 175 and 400

Exclusion Criteria:

• Acute diarrhea, bowel disorders due to an underlying cause

• Patient treated with MeteoSpasmyl® within the past 6 months

• Recent history of gastro intestinal surgery